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Cell fate decisions require the deployment of distinct transcriptional programs – 
how this is controlled and orchestrated is a key question from basic 
developmental biology to regenerative medicine. In this issue of The EMBO 
Journal, Pataskar and Jung et al. (Pataskar et al, 2015) demonstrate how the 
transcription factor NeuroD1 acts genome-wide to elicit a specific neurogenic 
program, including differentiation and migration. Much of that activity is due to 
NeuroD1 acting as a pioneer factor. NeuroD1 is able to bind its targets within 
repressive chromatin and can induce a more open chromatin state amenable to 
cell-type specific regulation. 
Main 
How the genome is regulated to give rise to the many distinct cell types of 
complex organisms is a primary focus of developmental biology today. With the 
advent of whole genome assays, it has become almost routine to probe cellular 
differentiation and identity at the genomic scale. This includes the profiling of 
transcription factors (TFs) to understand which genes they may regulate, but also the 
profiling of histone and DNA modifications to gain a more general understanding of 
the regulatory state of the genome.  
How, where, and when TFs act is as much a function of their own regulation, as of 
the specific cellular environment, including cofactor availability and the chromatin 
they must act within. Examples of the significance of this ‘cellular environment’ 
include that binding motif presence is often an extremely poor predictor of actual in 
vivo binding (e.g. Wilczynski & Furlong, 2010; Yang et al, 2006), and that individual 
cell types often demonstrate stark differences in the genome-wide distributions for the 
same sequence specific TFs (e.g. Cao et al, 2010; Odom et al, 2004). Several TFs 
have the capacity to fundamentally shape cellular identity and direct cell fate 
decisions (e.g.(Iwafuchi-Doi & Zaret, 2014; Lee et al, 1995) – understanding the 
mechanism by which these ‘pioneer’ factors are able to accomplish this feat is a 
matter of intense investigation. Pataskar and Jung et al. now show how a proneural 
TF called NeuroD1 navigates and modifies the local chromatin environment of 
progenitor cells to trigger differentiation and migration programs. 
The bHLH TF NeuroD1 had previously been shown to constitute a potent neuronal 
differentiation factor (e.g. Guo et al, 2014; Lee et al, 1995). To investigate how 
NeuroD1 imposes cell fate, the authors establish an embryonic stem cell (ESC) 
model, where the selective induction of NeuroD1 alone triggers neuronal 
differentiation, as shown by the loss of pluripotency markers, concomitant gain of 
neuronal markers, and changes in cellular morphology. Up-regulated genes (URGs) 
not only include neuronal differentiation factors, but also a significant number of 
genes implicated in epithelial-mesenchymal-transition (EMT) and migration, which is 
especially striking considering that NeuroD1 is primarily expressed in the 
subventricular zone (SVZ) of the developing brain, through which differentiating 
neurons migrate on their path from the progenitor population towards the cortical 
plate. 
Between the ~3900 genes that change expression in response to NeuroD1 and the 
~2400 binding events detected by ChIP, the authors concentrate on how NeuroD1 
interacts with the ~200 genes NeuroD1 seems to activate directly via binding to cis-
regulatory modules (CRMs), such as promoters and enhancers. Since many of these 
targets are TFs and chromatin regulators, a large part of the remainder of gene 
expression changes may be attributable to indirect regulation.  
Using Bayesian inference, Pataskar and Jung et al. searched for classifiers among 
ESC histone modification and TF binding data that distinguish NeuroD1-bound from 
non-bound CRMs near URGs. Compared to unbound URG promoters, bound URG 
promoters showed significantly higher levels of the chromatin condensation mark 
H3K27me3 and exhibited lower levels of activity hallmarks, such as H3K27ac and 
general chromatin accessibility in ESCs prior to NeuroD1 induction. Upon NeuroD1 
induction the chromatin at target promoters ‘opens’, marked by a decrease in 
H3K27me3 and increases in H3K27ac, general chromatin accessibility and gene 
expression. Similarly, target enhancers also gain chromatin hallmarks of activity. 
Time-course data at several CRMs reveal the sequence of events: NeuroD1 is bound 
quickly followed by H3K27 demethylation and acetylation, followed by RNA 
polymerase II engagement and transcription shortly thereafter. These observations 
strongly indicate that NeuroD1 is able to find and bind its targets in repressed 
chromatin, which then allows for chromatin remodelling towards a state more 
conducive to transcription – the very definition of a pioneer TF (Zaret & Carroll, 
2011). 
Interesting is the temporal requirement of pioneer factors: Is transient activity 
sufficient to switch chromatin state (and differentiation programs) long-term, or are 
they required to maintain the differentiation state? NeuroD1 expression is limited 
largely to the entry into and migration through the SVZ and is absent from 
differentiated neurons. The authors argue that a pulse of NeuroD1 induction likely 
suffices to reorganize chromatin longer-term: Target sites retain marks of chromatin 
activity state days after ectopic NeuroD1 expression is no longer detectable. However, 
to what degree this may be attributable to autoregulation of endogenous NeuroD1 
remains to be resolved. 
NeuroD1’s effects on gene activity and chromatin state hold up markedly well in 
vivo. Not only are individual URGs identified in vitro found to be co-expressed with 
NeuroD1 in the SVZ, but the actual binding of NeuroD1 to target CRMs was 
confirmed in the embryonic cortex. In an elegant assay of NeuroD1 overexpression in 
the developing brain, Pataskar and Jung et al. confirm that NeuroD1 increases H3K27 
acetylation at most target CRMs, coupled to an increase in target gene expression. 
Moreover, even the EMT stimulation identified in cultured cells is appreciable in the 
brain: within 48h after NeuroD1 is induced, cells have left the ventricular zone and 
lost expression of the neural progenitor marker Pax6. 
So here is a pioneer TF that once activated in pluripotent cells triggers wholesale 
changes in terms of cellular identity and migration behaviour. It does so in part by 
recognizing its binding motifs and activating differentiation genes even if they are 
located in repressive chromatin. This is followed by local remodelling of the 
chromatin towards a more open state, thus allowing for transcription. How does 
NeuroD1 achieve this? Part of the underlying mechanism will be interaction with 
other local TFs. The authors show that NeuroD1 binding correlates with displacement 
of TFs that were associated with the URG promoters (Tbx3) and enhancers (Mbd3, 
Tbx3). While the mechanisms of this displacement are not clear, the biological 
implications are: Mbd3 is a component of the nucleosome remodelling deacetylase 
complex (NuRD) that would help silence enhancers. Similarly, the sequence-specific 
T-box TF Tbx3 has been described as a potent repressor. Local displacement of 
factors such as Mbd3 and Tbx3 upon NeuroD1 binding should then allow relief of 
direct and chromatin-mediated repression at CRMs and allow for regulation by 
additional non-pioneer (aka. ‘settler’) TFs. Clearly, the hierarchies and mechanisms 
underlying chromatin remodelling in response to NeuroD1 and other pioneers remain 
to be elucidated. Since Utf1, Mbd3 and Tbx3 association were found to be predictive 
for later NeuroD1 binding, one might speculate whether some of these factors may 
play a role in recruiting NeuroD1 to its targets. Soufi et al. recently proposed that 
some bHLH pioneers (like Myc) bind their targets primarily through cooperative 
interaction with local factors, while other bHLHs rely on their own binding activity 
(Soufi et al, 2015). Where NeuroD1 fits on that spectrum is not yet clear.  
Among pioneers, the bHLH TFs may be an especially interesting class. Most are 
able to form homo- and heterodimers, which affects their precise binding specificity 
and their molecular activity. Hence, for bHLH pioneers, the specific dimers formed 
may well dictate where they modify chromatin state, as well as how they modify it. It 
is feasible, for example, that the NeuroD1 binding detected in CRMs of up-regulated 
genes could reflect dimers distinct from NeuroD1 complexes near repressed genes. 
Furthermore, NeuroD1 may mediate distinct pioneer activities in other progenitor cell 
types. NeuroD1 (aka. Beta2) is also an essential component in the differentiation and 
maintenance of the mature pancreatic β-cell state (Jia et al, 2015), where it is likely 
forming complexes distinct from those in neuronal progenitors. 
We are only just beginning to understand the complexities of pioneer activity in 
terms of how such TFs interact with their chromatinized targets, as well as in terms of 
the molecular activities they deliver to those targets. Once bound, pioneers like 
NeuroD1 can be thought of as (re-)partitioners of the regulatable genome: By 
modulating chromatin state locally in a tissue- or condition-specific manner, they 
change accessibility for further regulators. A detailed understanding of the 
hierarchical interactions of ‘pioneers’ and ‘settlers’ with their chromatin environment 
is an essential prerequisite for predictive modelling of how gene expression 
programmes are deployed to guide cellular differentiation. 
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Local chromatin remodelling by pioneers. A genomic region is condensed and genes within are 
repressed. Repressor proteins (R1-3) such as Mbd3, Utf1and Tbx3 maintain the repressive chromatin 
state and reinforce transcriptional silence. Once available, pioneer factor complexes (P) like 
NeuroD1+bHLH partners find and bind their target sites, including sites within repressive chromatin. 
This then recruits enzymatic activities to modulate repression locally. For example, repressor proteins 
like Tbx3 and Mbd3 are ejected and histone trimethylation of H3K27 can be exchanged for acetylation. 
Chromatin locally decondenses in the process and ‘opens’ for targeting by settler transcription factors 
(TF1-3) to regulate gene expression either in conjunction with, or independent of the pioneer complex. 
Complex context-dependent regulation is achieved by, for example, (i) availability of pioneer binding 
partners / cofactors, (ii) aspects of the chromatin environment, including recruiting factors already 
present, (iii) the mode of pioneer interaction with the chromatin (e.g. displacement of proteins, delivery 
of HAT activities, etc.), and (iv) the specific availability of TFs capable of translating the regulatory 
information encoded in open chromatin into local gene activity. 
